No abstract available
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adult
-
Antineoplastic Agents / therapeutic use
-
Core Binding Factor Alpha 2 Subunit / genetics
-
Cytarabine / therapeutic use
-
Female
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Idarubicin / therapeutic use
-
Leukemia, Myeloid, Acute / diagnosis
-
Leukemia, Myeloid, Acute / genetics
-
Leukemia, Myeloid, Acute / therapy*
-
Male
-
Neoplasm, Residual / diagnosis
-
Neoplasm, Residual / genetics
-
Neoplasm, Residual / therapy*
-
Oncogene Proteins, Fusion / genetics
-
RUNX1 Translocation Partner 1 Protein
Substances
-
AML1-ETO fusion protein, human
-
Antineoplastic Agents
-
Core Binding Factor Alpha 2 Subunit
-
Oncogene Proteins, Fusion
-
RUNX1 Translocation Partner 1 Protein
-
Cytarabine
-
Idarubicin